HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SP-420

an iron chelating agent

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Aydinok, Yesim: 1 article (12/2017)
2.	Berk, Gregory: 1 article (12/2017)
3.	Cohen, Alan R: 1 article (12/2017)
4.	Giardina, Patricia J: 1 article (12/2017)
5.	Jeglinski, Brenda I: 1 article (12/2017)
6.	Kuo, Kevin H: 1 article (12/2017)
7.	Kwiatkowski, Janet L: 1 article (12/2017)
8.	Neufeld, Ellis J: 1 article (12/2017)
9.	Pietropaolo, Keith: 1 article (12/2017)
10.	Saliba, Antoine N: 1 article (12/2017)

Related Diseases

1.	Thalassemia 12/01/2017 - "Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia." 12/01/2017 - "Our phase I, open-label, multi-center, dose-escalation study evaluated the pharmacokinetics (PK) of SP-420, a tridentate oral iron chelating agent of the desferrithiocin class, in patients with transfusion dependent β-thalassemia. "

Related Drugs and Biologics

1.	Iron
2.	Chelating Agents
3.	desferrithiocin